HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:HI • IT0005585861

298 EUR
+2 (+0.68%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

5

Overall HI gets a fundamental rating of 5 out of 10. We evaluated HI against 29 industry peers in the Health Care Providers & Services industry. HI gets an excellent profitability rating and is at the same time showing great financial health properties. HI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year HI was profitable.
  • HI had a positive operating cash flow in the past year.
  • HI had positive earnings in each of the past 5 years.
  • In the past 5 years HI always reported a positive cash flow from operatings.
HI.MI Yearly Net Income VS EBIT VS OCF VS FCFHI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • With an excellent Return On Assets value of 6.33%, HI belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
  • HI has a better Return On Equity (12.31%) than 68.97% of its industry peers.
  • The Return On Invested Capital of HI (7.54%) is better than 75.86% of its industry peers.
  • HI had an Average Return On Invested Capital over the past 3 years of 7.13%. This is in line with the industry average of 6.49%.
  • The 3 year average ROIC (7.13%) for HI is below the current ROIC(7.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROIC 7.54%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
HI.MI Yearly ROA, ROE, ROICHI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.64%, HI belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
  • HI's Profit Margin has improved in the last couple of years.
  • The Operating Margin of HI (13.27%) is better than 93.10% of its industry peers.
  • HI's Operating Margin has improved in the last couple of years.
  • HI's Gross Margin of 29.23% is fine compared to the rest of the industry. HI outperforms 62.07% of its industry peers.
  • HI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
HI.MI Yearly Profit, Operating, Gross MarginsHI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HI is still creating some value.
  • HI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HI has been reduced compared to 5 years ago.
  • The debt/assets ratio for HI has been reduced compared to a year ago.
HI.MI Yearly Shares OutstandingHI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HI.MI Yearly Total Debt VS Total AssetsHI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.15 indicates that HI is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.15, HI belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
  • HI has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • HI has a better Debt to Equity ratio (0.30) than 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.15
ROIC/WACC1.02
WACC7.41%
HI.MI Yearly LT Debt VS Equity VS FCFHI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.47 indicates that HI has no problem at all paying its short term obligations.
  • HI has a Current ratio of 2.47. This is amongst the best in the industry. HI outperforms 96.55% of its industry peers.
  • A Quick Ratio of 2.47 indicates that HI has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.47, HI belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
HI.MI Yearly Current Assets VS Current LiabilitesHI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.67% over the past year.
  • The Earnings Per Share has been growing by 181.50% on average over the past years. This is a very strong growth
  • Looking at the last year, HI shows a decrease in Revenue. The Revenue has decreased by -4.22% in the last year.
  • The Revenue has been growing slightly by 2.37% on average over the past years.
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.38, the valuation of HI can be described as rather expensive.
  • HI's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of HI to the average of the S&P500 Index (28.03), we can say HI is valued slightly cheaper.
Industry RankSector Rank
PE 18.38
Fwd PE N/A
HI.MI Price Earnings VS Forward Price EarningsHI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as HI.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.83
HI.MI Per share dataHI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The excellent profitability rating of HI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • HI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HEALTH ITALIA SPA

BIT:HI (2/6/2026, 7:00:00 PM)

298

+2 (+0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.62M
Revenue(TTM)35.60M
Net Income(TTM)3.08M
Analysts84.44
Price Target372.3 (24.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.38
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF 44.77
P/B 2.26
P/tB 2.66
EV/EBITDA 9.83
EPS(TTM)16.21
EY5.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.46
FCFYN/A
OCF(TTM)6.66
OCFY2.23%
SpS187.37
BVpS131.59
TBVpS112.11
PEG (NY)N/A
PEG (5Y)0.1
Graham Number219.08
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROCE 13.76%
ROIC 7.54%
ROICexc 8.33%
ROICexgc 9.39%
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
FCFM N/A
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexgc growth 3Y-3.65%
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 1.28
Cap/Depr 242.82%
Cap/Sales 7.54%
Interest Coverage 250
Cash Conversion 21.7%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 3.15
F-Score4
WACC7.41%
ROIC/WACC1.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.56%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.27%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y-61.44%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%

HEALTH ITALIA SPA / HI.MI FAQ

What is the ChartMill fundamental rating of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HI.MI.


What is the valuation status of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTH ITALIA SPA (HI.MI). This can be considered as Overvalued.


How profitable is HEALTH ITALIA SPA (HI.MI) stock?

HEALTH ITALIA SPA (HI.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HI stock?

The Price/Earnings (PE) ratio for HEALTH ITALIA SPA (HI.MI) is 18.38 and the Price/Book (PB) ratio is 2.26.


Can you provide the dividend sustainability for HI stock?

The dividend rating of HEALTH ITALIA SPA (HI.MI) is 0 / 10 and the dividend payout ratio is 0%.